IO BIOTECH INC (IOBT)
US4497781090 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -90.34M | -86.08M | -71.46M | -67.88M | -12.04M | |||
| Depreciation Amortization | 244.00K | 215.00K | 100.00K | N/A | N/A | |||
| Change In Working Capital | -917.00K | 5.87M | 4.24M | -780.00K | 150.00K | |||
| Other non cash items | 5.50M | 8.27M | 7.39M | 28.01M | 1.94M | |||
| OPERATING CASH FLOW | -85.52M | -71.74M | -59.73M | -40.65M | -9.96M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -146.00K | -323.00K | -690.00K | -150.00K | N/A | |||
| INVESTING CASH FLOW | -146.00K | -323.00K | -690.00K | -150.00K | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | N/A | 75.06M | 0.00 | 265.06M | 5.12M | |||
| Other Financing Activity | -75.07M | -3.20M | 0.00 | -12.11M | -10.00K | |||
| FINANCING CASH FLOW | -10.00K | 71.86M | 0.00 | 252.95M | 5.10M | |||
| Exchange Rate Effect | 360.00K | 803.00K | -8.52M | -3.76M | 410.00K | |||
| CHANGE IN CASH | -85.31M | 603.00K | -68.94M | 208.39M | -4.44M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -85.52M | -71.74M | -59.73M | -40.65M | -9.96M | |||
| Capital Expenditure | -146.00K | -323.00K | -690.00K | -150.00K | N/A | |||
| FREE CASH FLOW | -85.66M | -72.06M | -60.42M | -40.80M | -9.96M | |||
All data in USD